These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
465 related items for PubMed ID: 18634163
21. Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Keystone E, Fleischmann R, Emery P, Furst DE, van Vollenhoven R, Bathon J, Dougados M, Baldassare A, Ferraccioli G, Chubick A, Udell J, Cravets MW, Agarwal S, Cooper S, Magrini F. Arthritis Rheum; 2007 Dec; 56(12):3896-908. PubMed ID: 18050221 [Abstract] [Full Text] [Related]
22. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry. Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA, RADIUS Investigators. Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444 [Abstract] [Full Text] [Related]
23. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate. O'Dell JR, Haire C, Erikson N, Drymalski W, Palmer W, Maloley P, Klassen LW, Wees S, Moore GF. J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058 [Abstract] [Full Text] [Related]
24. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Lequerré T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, Kone-Paut I, Michel M, Dernis E, Khellaf M, Limal N, Job-Deslandre C, Fautrel B, Le Loët X, Sibilia J, Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie (SOFREMIP), Club Rhumatismes et Inflammation (CRI). Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302 [Abstract] [Full Text] [Related]
25. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial. Mease PJ, Revicki DA, Szechinski J, Greenwald M, Kivitz A, Barile-Fabris L, Kalsi J, Eames J, Leirisalo-Repo M. J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385 [Abstract] [Full Text] [Related]
26. The methotrexate therapeutic response in rheumatoid arthritis. Ortendahl M, Holmes T, Schettler JD, Fries JF. J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316 [Abstract] [Full Text] [Related]
27. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators. Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331 [Abstract] [Full Text] [Related]
28. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial. van der Heijde D, Klareskog L, Singh A, Tornero J, Melo-Gomes J, Codreanu C, Pedersen R, Freundlich B, Fatenejad S. Ann Rheum Dis; 2006 Mar; 65(3):328-34. PubMed ID: 16079172 [Abstract] [Full Text] [Related]
29. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability. Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N, Singh G, Yamanaka H. Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459 [Abstract] [Full Text] [Related]
30. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience. Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, Kunkel G, Schlesinger M, Bohnsack J. J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453 [Abstract] [Full Text] [Related]
31. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects. Hurst S, Kallan MJ, Wolfe FJ, Fries JF, Albert DA. J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722 [Abstract] [Full Text] [Related]
32. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. Sokka T, Pincus T. J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145 [Abstract] [Full Text] [Related]
33. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs. Malysheva OA, Wahle M, Wagner U, Pierer M, Arnold S, Häntzschel H, Baerwald CG. J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314 [Abstract] [Full Text] [Related]
34. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M. Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599 [Abstract] [Full Text] [Related]
35. Addressing the safety of anakinra in patients with rheumatoid arthritis. Fleischmann RM. Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii29-35. PubMed ID: 12817093 [Abstract] [Full Text] [Related]
36. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA. Keystone E, Freundlich B, Schiff M, Li J, Hooper M. J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659 [Abstract] [Full Text] [Related]
37. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Cañete JD, Suárez B, Hernández MV, Sanmartí R, Rego I, Celis R, Moll C, Pinto JA, Blanco FJ, Lozano F. Ann Rheum Dis; 2009 Oct; 68(10):1547-52. PubMed ID: 18930989 [Abstract] [Full Text] [Related]
38. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Ogrendik M. Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134 [Abstract] [Full Text] [Related]
39. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial. Matteson EL, Weyand CM, Fulbright JW, Christianson TJ, McClelland RL, Goronzy JJ. Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105 [Abstract] [Full Text] [Related]
40. Patient-derived joint counts are a potential alternative for determining Disease Activity Score. Kavanaugh A, Lee SJ, Weng HH, Chon Y, Huang XY, Lin SL. J Rheumatol; 2010 May; 37(5):1035-41. PubMed ID: 20156946 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]